Glenmark Pharmaceuticals, USA has received final approval by the United States Food & Drug Administration (US FDA) for Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules, 1 mg/20 mcg, the generic version of Taytulla Capsules, of Allergan Pharmaceuticals International.
New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Loestrin tablets used to prevent pregnancy.
Allergan Issues Nationwide Voluntary Recall of TAYTULLA® Softgel Capsules 1mg/20mcg
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets, 1 mg/20 mcg, the generic version of Minastrin®1 24 Fe Tablets, of Allergan Pharmaceuticals International Limited.
Mylan Lab’s Generic Ethinyl Estradiol; Norethindrone Acetate Receives Approval In US
Enforcement Report - Week of August 23, 2017
Aurobindo Pharma’s Generic Cigensa Norethindrone Acetate;Ethinyl Estradiol; Ethinyl Estradiol;Ferrous Fumarate Receives Tentative Approval In US
Enforcement Report - Week of May 31, 2017
Lupin Pharmaceuticals Inc. Announces a Nationwide Recall of Mibelas™ 24 Fe Tablets Due to Out of Sequence Tablets and Missing Expiry/Lot Information
TAYTULLA will be commercially available in blister cards containing 24 oval, opaque, pale pink (active) soft gelatin capsules, each containing 1 mg norethindrone acetate and 20 mcg ethinyl estradiol, and 4 oval, opaque, maroon (nonhormonal placebo) capsules containing iron.